Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer

A longitudinal study

Nobuya Akizuki, Ken Shimizu, Mariko Asai, Tomohito Nakano, Takuji Okusaka, Kazuaki Shimada, Hironobu Inoguchi, Masatoshi Inagaki, Maiko Fujimori, Tatsuo Akechi, Yosuke Uchitomi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: It is known that depression and anxiety occur more frequently in pancreatic cancer patients than in those with other malignancies. However, few studies have assessed depression and anxiety using reliable psychiatric diagnostic tools. The purpose of this study was to determine the prevalence of depression and anxiety among pancreatic cancer patients before and 1 month after the start of anticancer treatment using reliable psychiatric diagnostic tools, and to identify factors that predict their occurrence. Methods: Pancreatic cancer patients were consecutively recruited. Structured clinical interviews were used to determine the presence of affective disorders, anxiety disorders and adjustment disorders. Baseline interviews were performed prior to initiation of anticancer treatment, while follow-up interviews were performed 1 month after treatment was started. Medical, demographic and psychosocial backgrounds were also assessed as predictive factors. Results: One hundred and ten patients participated in the baseline interview and 91 in the follow-up interview. Depression and anxiety were observed in 15 patients (13.6%) at the baseline, and 15 patients (16.5%) at the follow-up. Lack of confidants was associated with depression and anxiety at the baseline. At the baseline, sadness, lower Karnofsky Performance Status and prior experience with the death of a family member due to cancer predicted newly diagnosed depression and anxiety at the follow-up. Conclusion: A considerable percentage of pancreatic cancer patients experienced depression and anxiety. Multidimensional psychosocial predictive factors were found and optimal psychological care should incorporate early detection of sadness.

Original languageEnglish
Pages (from-to)71-77
Number of pages7
JournalJapanese Journal of Clinical Oncology
Volume46
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Pancreatic Neoplasms
Longitudinal Studies
Anxiety
Depression
Interviews
Psychiatry
Psychology
Adjustment Disorders
Karnofsky Performance Status
Anxiety Disorders
Mood Disorders
Neoplasms
Therapeutics
Demography

Keywords

  • Anxiety
  • Depression
  • Pancreatic neoplasms
  • Prevalence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer : A longitudinal study. / Akizuki, Nobuya; Shimizu, Ken; Asai, Mariko; Nakano, Tomohito; Okusaka, Takuji; Shimada, Kazuaki; Inoguchi, Hironobu; Inagaki, Masatoshi; Fujimori, Maiko; Akechi, Tatsuo; Uchitomi, Yosuke.

In: Japanese Journal of Clinical Oncology, Vol. 46, No. 1, 01.01.2016, p. 71-77.

Research output: Contribution to journalArticle

Akizuki, N, Shimizu, K, Asai, M, Nakano, T, Okusaka, T, Shimada, K, Inoguchi, H, Inagaki, M, Fujimori, M, Akechi, T & Uchitomi, Y 2016, 'Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer: A longitudinal study', Japanese Journal of Clinical Oncology, vol. 46, no. 1, pp. 71-77. https://doi.org/10.1093/jjco/hyv169
Akizuki, Nobuya ; Shimizu, Ken ; Asai, Mariko ; Nakano, Tomohito ; Okusaka, Takuji ; Shimada, Kazuaki ; Inoguchi, Hironobu ; Inagaki, Masatoshi ; Fujimori, Maiko ; Akechi, Tatsuo ; Uchitomi, Yosuke. / Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer : A longitudinal study. In: Japanese Journal of Clinical Oncology. 2016 ; Vol. 46, No. 1. pp. 71-77.
@article{e8a6402cf7a44e199d6a4f1be06f98d0,
title = "Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer: A longitudinal study",
abstract = "Objective: It is known that depression and anxiety occur more frequently in pancreatic cancer patients than in those with other malignancies. However, few studies have assessed depression and anxiety using reliable psychiatric diagnostic tools. The purpose of this study was to determine the prevalence of depression and anxiety among pancreatic cancer patients before and 1 month after the start of anticancer treatment using reliable psychiatric diagnostic tools, and to identify factors that predict their occurrence. Methods: Pancreatic cancer patients were consecutively recruited. Structured clinical interviews were used to determine the presence of affective disorders, anxiety disorders and adjustment disorders. Baseline interviews were performed prior to initiation of anticancer treatment, while follow-up interviews were performed 1 month after treatment was started. Medical, demographic and psychosocial backgrounds were also assessed as predictive factors. Results: One hundred and ten patients participated in the baseline interview and 91 in the follow-up interview. Depression and anxiety were observed in 15 patients (13.6{\%}) at the baseline, and 15 patients (16.5{\%}) at the follow-up. Lack of confidants was associated with depression and anxiety at the baseline. At the baseline, sadness, lower Karnofsky Performance Status and prior experience with the death of a family member due to cancer predicted newly diagnosed depression and anxiety at the follow-up. Conclusion: A considerable percentage of pancreatic cancer patients experienced depression and anxiety. Multidimensional psychosocial predictive factors were found and optimal psychological care should incorporate early detection of sadness.",
keywords = "Anxiety, Depression, Pancreatic neoplasms, Prevalence",
author = "Nobuya Akizuki and Ken Shimizu and Mariko Asai and Tomohito Nakano and Takuji Okusaka and Kazuaki Shimada and Hironobu Inoguchi and Masatoshi Inagaki and Maiko Fujimori and Tatsuo Akechi and Yosuke Uchitomi",
year = "2016",
month = "1",
day = "1",
doi = "10.1093/jjco/hyv169",
language = "English",
volume = "46",
pages = "71--77",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer

T2 - A longitudinal study

AU - Akizuki, Nobuya

AU - Shimizu, Ken

AU - Asai, Mariko

AU - Nakano, Tomohito

AU - Okusaka, Takuji

AU - Shimada, Kazuaki

AU - Inoguchi, Hironobu

AU - Inagaki, Masatoshi

AU - Fujimori, Maiko

AU - Akechi, Tatsuo

AU - Uchitomi, Yosuke

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Objective: It is known that depression and anxiety occur more frequently in pancreatic cancer patients than in those with other malignancies. However, few studies have assessed depression and anxiety using reliable psychiatric diagnostic tools. The purpose of this study was to determine the prevalence of depression and anxiety among pancreatic cancer patients before and 1 month after the start of anticancer treatment using reliable psychiatric diagnostic tools, and to identify factors that predict their occurrence. Methods: Pancreatic cancer patients were consecutively recruited. Structured clinical interviews were used to determine the presence of affective disorders, anxiety disorders and adjustment disorders. Baseline interviews were performed prior to initiation of anticancer treatment, while follow-up interviews were performed 1 month after treatment was started. Medical, demographic and psychosocial backgrounds were also assessed as predictive factors. Results: One hundred and ten patients participated in the baseline interview and 91 in the follow-up interview. Depression and anxiety were observed in 15 patients (13.6%) at the baseline, and 15 patients (16.5%) at the follow-up. Lack of confidants was associated with depression and anxiety at the baseline. At the baseline, sadness, lower Karnofsky Performance Status and prior experience with the death of a family member due to cancer predicted newly diagnosed depression and anxiety at the follow-up. Conclusion: A considerable percentage of pancreatic cancer patients experienced depression and anxiety. Multidimensional psychosocial predictive factors were found and optimal psychological care should incorporate early detection of sadness.

AB - Objective: It is known that depression and anxiety occur more frequently in pancreatic cancer patients than in those with other malignancies. However, few studies have assessed depression and anxiety using reliable psychiatric diagnostic tools. The purpose of this study was to determine the prevalence of depression and anxiety among pancreatic cancer patients before and 1 month after the start of anticancer treatment using reliable psychiatric diagnostic tools, and to identify factors that predict their occurrence. Methods: Pancreatic cancer patients were consecutively recruited. Structured clinical interviews were used to determine the presence of affective disorders, anxiety disorders and adjustment disorders. Baseline interviews were performed prior to initiation of anticancer treatment, while follow-up interviews were performed 1 month after treatment was started. Medical, demographic and psychosocial backgrounds were also assessed as predictive factors. Results: One hundred and ten patients participated in the baseline interview and 91 in the follow-up interview. Depression and anxiety were observed in 15 patients (13.6%) at the baseline, and 15 patients (16.5%) at the follow-up. Lack of confidants was associated with depression and anxiety at the baseline. At the baseline, sadness, lower Karnofsky Performance Status and prior experience with the death of a family member due to cancer predicted newly diagnosed depression and anxiety at the follow-up. Conclusion: A considerable percentage of pancreatic cancer patients experienced depression and anxiety. Multidimensional psychosocial predictive factors were found and optimal psychological care should incorporate early detection of sadness.

KW - Anxiety

KW - Depression

KW - Pancreatic neoplasms

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84954505229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954505229&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyv169

DO - 10.1093/jjco/hyv169

M3 - Article

VL - 46

SP - 71

EP - 77

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 1

ER -